Aprotinin for Primary Coronary Artery Bypass Grafting: A Multicenter Trial of Three Dose Regimens
- 1 December 1996
- journal article
- clinical trial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 62 (6) , 1659-1667
- https://doi.org/10.1016/s0003-4975(96)00451-1
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A Multicenter, Double-Blind, Placebo-Controlled Trial of Aprotinin for Reducing Blood Loss and the Requirement for Donor-Blood Transfusion in Patients Undergoing Repeat Coronary Artery Bypass GraftingCirculation, 1995
- Half-dose aprotinin preserves hemostatic function in patients undergoing bypass operationsThe Annals of Thoracic Surgery, 1995
- AprotininDrugs, 1995
- Aprotinin in elective primary bypass surgeryGraft patency and clinical efficacyEuropean Journal of Cardio-Thoracic Surgery, 1995
- Aprotinin for coronary bypass operations: Efficacy, safety, and influence on early saphenous vein graft patencyThe Journal of Thoracic and Cardiovascular Surgery, 1994
- Aprotinin therapy in cardiac operations: A report on use in 41 cardiac centers in the United KingdomThe Annals of Thoracic Surgery, 1993
- Low-dose aprotinin in internal mammary artery bypass operations contributes to important blood savingThe Annals of Thoracic Surgery, 1992
- Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled studyThe Annals of Thoracic Surgery, 1992
- Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypassThe Annals of Thoracic Surgery, 1991
- The Electrocardiogram in Population StudiesCirculation, 1960